{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:37:42Z","timestamp":1787002662894,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41401-025-01700-w","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T08:59:49Z","timestamp":1768381189000},"page":"1117-1131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["G protein-dependent dopamine D2 receptor signaling mediates cocaine-primed reinstatement"],"prefix":"10.1038","volume":"47","author":[{"given":"Hai-bo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-min","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"1700_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173210","volume":"208","author":"ME Carroll","year":"2021","unstructured":"Carroll ME. Voluntary exercise as a treatment for incubated and expanded drug craving leading to relapse to addiction: animal models. Pharmacol Biochem Behav. 2021;208:173210.","journal-title":"Pharmacol Biochem Behav"},{"key":"1700_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1749-6632.1992.tb25984.x","volume":"654","author":"CP O\u2019Brien","year":"1992","unstructured":"O\u2019Brien CP, Childress AR, McLellan AT, Ehrman R. Classical conditioning in drug-dependent humans. Ann N Y Acad Sci. 1992;654:400\u201315.","journal-title":"Ann N Y Acad Sci"},{"key":"1700_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1037\/1064-1297.4.1.5","volume":"4","author":"H de Wit","year":"1996","unstructured":"de Wit H. Priming effects with drugs and other reinforcers. Exp Clin Psychopharmacol. 1996;4:5\u201310.","journal-title":"Exp Clin Psychopharmacol"},{"key":"1700_CR4","first-page":"125","volume":"25","author":"J Stewart","year":"2000","unstructured":"Stewart J. Pathways to relapse: The neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci. 2000;25:125\u201336.","journal-title":"J Psychiatry Neurosci"},{"key":"1700_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","volume":"168","author":"Y Shaham","year":"2003","unstructured":"Shaham Y, Shalev U, Lu L, de Wit H, Stewart J. The reinstatement model of drug relapse: History, methodology and major findings. Psychopharmacology (Berl). 2003;168:3\u201320.","journal-title":"Psychopharmacology (Berl)"},{"key":"1700_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1124\/pr.115.011668","volume":"68","author":"PW Czoty","year":"2016","unstructured":"Czoty PW, Stoops WW, Rush CR. Evaluation of the \u201cpipeline\u201d for development of medications for cocaine use disorder: A review of translational preclinical, human laboratory, and clinical trial research. Pharmacol Rev. 2016;68:533\u201362.","journal-title":"Pharmacol Rev"},{"key":"1700_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00213-006-0473-5","volume":"191","author":"DL Graham","year":"2007","unstructured":"Graham DL, Hoppenot R, Hendryx A, Self DW. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats. Psychopharmacology. 2007;191:719\u201330.","journal-title":"Psychopharmacology"},{"key":"1700_CR8","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s12264-023-01059-0","volume":"39","author":"R-R Hu","year":"2023","unstructured":"Hu R-R, Yang M-D, Ding X-Y, Wu N, Li J, Song R. Blockade of the dopamine D3 receptor attenuates opioids-induced addictive behaviours associated with inhibiting the mesolimbic dopamine system. Neurosci Bull. 2023;39:1655\u201368.","journal-title":"Neurosci Bull"},{"key":"1700_CR9","doi-asserted-by":"crossref","unstructured":"Sibley DR, Monsma FJ, Shen Y. Molecular neurobiology of dopaminergic receptors. In: Bradley RJ, Harris RA, editors. Int Rev Neurobiol, 1993. p. 391\u2013415.","DOI":"10.1016\/S0074-7742(08)60573-5"},{"key":"1700_CR10","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.271.5255.1586","volume":"271","author":"DW Self","year":"1996","unstructured":"Self DW, Barnhart WJ, Lehman DA, Nestler EJ. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science. 1996;271:1586\u20139.","journal-title":"Science"},{"key":"1700_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s002130050944","volume":"143","author":"TJ De Vries","year":"1999","unstructured":"De Vries TJ, Schoffelmeer ANM, Binnekade R, Vanderschuren LJMJ. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology (Berl). 1999;143:254\u201360.","journal-title":"Psychopharmacology (Berl)"},{"key":"1700_CR12","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0022-3565(24)39122-0","volume":"294","author":"TV Khroyan","year":"2000","unstructured":"Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: Effects of selective antagonists and agonists. J Pharmacol Exp Ther. 2000;294:680\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"1700_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1460-9568.2005.04524.x","volume":"23","author":"HD Schmidt","year":"2006","unstructured":"Schmidt HD, Anderson SM, Pierce RC. Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behaviour in the rat. Eur J Neurosci. 2006;23:219\u201328.","journal-title":"Eur J Neurosci"},{"key":"1700_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF02247382","volume":"126","author":"R Weissenborn","year":"1996","unstructured":"Weissenborn R, Deroche V, Koob GF, Weiss F. Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus. Psychopharmacology. 1996;126:311\u201322.","journal-title":"Psychopharmacology"},{"key":"1700_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0091-3057(99)00049-0","volume":"64","author":"RD Spealman","year":"1999","unstructured":"Spealman RD, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV. Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharm Biochem Behav. 1999;64:327\u201336.","journal-title":"Pharm Biochem Behav"},{"key":"1700_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00213-002-1276-y","volume":"168","author":"S Schenk","year":"2003","unstructured":"Schenk S, Gittings D. Effects of SCH 23390 and eticlopride on cocaine-seeking produced by cocaine and WIN 35,428 in rats. Psychopharmacology. 2003;168:118\u201323.","journal-title":"Psychopharmacology"},{"key":"1700_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kebabian","year":"1979","unstructured":"Kebabian JW, Caine DB. Multiple receptors for dopamine. Nature. 1979;277:93\u20136.","journal-title":"Nature"},{"key":"1700_CR18","doi-asserted-by":"publisher","first-page":"8147","DOI":"10.1523\/JNEUROSCI.17-21-08147.1997","volume":"17","author":"A Nishi","year":"1997","unstructured":"Nishi A, Snyder GL, Greengard P. Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J Neurosci J Soc Neurosci. 1997;17:8147\u201355.","journal-title":"J Neurosci J Soc Neurosci"},{"key":"1700_CR19","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1002\/anie.201301924","volume":"52","author":"RJ Lefkowitz","year":"2013","unstructured":"Lefkowitz RJ. A brief history of G-protein coupled receptors (Nobel Lecture). Angew Chem Int Ed Engl. 2013;52:6366\u201378.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1700_CR20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/35047086","volume":"408","author":"LM Bohn","year":"2000","unstructured":"Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature. 2000;408:720\u20133.","journal-title":"Nature"},{"key":"1700_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","volume":"17","author":"EJ Whalen","year":"2011","unstructured":"Whalen EJ, Rajagopal S, Lefkowitz RJ. Therapeutic potential of \u03b2-arrestin- and G protein-biased agonists. Trends Mol Med. 2011;17:126\u201339.","journal-title":"Trends Mol Med"},{"key":"1700_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nn1846","volume":"10","author":"S Vijayraghavan","year":"2007","unstructured":"Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AFT. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci. 2007;10:376\u201384.","journal-title":"Nat Neurosci"},{"key":"1700_CR23","doi-asserted-by":"publisher","first-page":"E2517","DOI":"10.1073\/pnas.1502740112","volume":"112","author":"NM Urs","year":"2015","unstructured":"Urs NM, Bido S, Peterson SM, Daigle TL, Bass CE, Gainetdinov RR, et al. Targeting \u03b2-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2015;112:E2517\u20132526.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1700_CR24","doi-asserted-by":"publisher","first-page":"18488","DOI":"10.1073\/pnas.1104807108","volume":"108","author":"JA Allen","year":"2011","unstructured":"Allen JA, Yost JM, Setola V, Chen X, Sassano MF, Chen M, et al. Discovery of \u03b2-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci USA. 2011;108:18488\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1700_CR25","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1021\/acschembio.8b00168","volume":"13","author":"M We\u00efwer","year":"2018","unstructured":"We\u00efwer M, Xu Q, Gale JP, Lewis M, Campbell AJ, Schroeder FA, et al. Functionally biased D2R antagonists: targeting the \u03b2-arrestin pathway to improve antipsychotic treatment. ACS Chem Biol. 2018;13:1038\u201347.","journal-title":"ACS Chem Biol"},{"key":"1700_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41380-022-01884-1","volume":"28","author":"G He","year":"2023","unstructured":"He G, Huai Z, Jiang C, Huang B, Tian Z, Le Q, et al. Persistent increase of accumbens cocaine ensemble excitability induced by IRK downregulation after withdrawal mediates the incubation of cocaine craving. Mol Psychiatry. 2023;28:448\u201362.","journal-title":"Mol Psychiatry"},{"key":"1700_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2024.102573","volume":"234","author":"Z Huai","year":"2024","unstructured":"Huai Z, Huang B, He G, Li H, Liu Y, Le Q, et al. Accumulation of NMDA receptors in accumbal neuronal ensembles mediates increased conditioned place preference for cocaine after prolonged withdrawal. Prog Neurobiol. 2024;234:102573.","journal-title":"Prog Neurobiol"},{"key":"1700_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41422-021-00588-5","volume":"32","author":"Z Liu","year":"2022","unstructured":"Liu Z, Le Q, Lv Y, Chen X, Cui J, Zhou Y, et al. A distinct D1-MSN subpopulation down-regulates dopamine to promote negative emotional state. Cell Res. 2022;32:139\u201356.","journal-title":"Cell Res"},{"key":"1700_CR29","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/s41386-024-01905-3","volume":"49","author":"MF Barbano","year":"2024","unstructured":"Barbano MF, Qi J, Chen E, Mohammad U, Espinoza O, Candido M, et al. VTA glutamatergic projections to the nucleus accumbens suppress psychostimulant-seeking behavior. Neuropsychopharmacology. 2024;49:1905\u201315.","journal-title":"Neuropsychopharmacology"},{"key":"1700_CR30","doi-asserted-by":"crossref","unstructured":"Barry SM, Huebschman JL, Devries DM, McCue LM, Tsvetkov E, Akiki RM, et al. Histone deacetylase 5 in prelimbic prefrontal cortex limits context-associated cocaine seeking. Biol Psychiatry, 2025;7:S0006-3223(25)01301-0.","DOI":"10.1101\/2024.09.21.614125"},{"key":"1700_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.73","volume":"3","author":"Y Gao","year":"2015","unstructured":"Gao Y, Peterson S, Masri B, Hougland MT, Adham N, Gyerty\u00e1n I, et al. Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor \u03b2-arrestin interactions. Pharmacol Res Perspect. 2015;3:e00073.","journal-title":"Pharmacol Res Perspect"},{"key":"1700_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1124\/mol.113.090563","volume":"86","author":"RB Free","year":"2014","unstructured":"Free RB, Chun LS, Moritz AE, Miller BN, Doyle TB, Conroy JL, et al. Discovery and characterization of a G protein-biased agonist that inhibits \u03b2-arrestin recruitment to the D2 dopamine receptor. Mol Pharmacol. 2014;86:96\u2013105.","journal-title":"Mol Pharmacol"},{"key":"1700_CR33","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41386-024-01867-6","volume":"49","author":"M Lenoir","year":"2024","unstructured":"Lenoir M, Engeln M, Navailles S, Girardeau P, Ahmed SH. A large-scale c-fos brain mapping study on extinction of cocaine-primed reinstatement. Neuropsychopharmacology. 2024;49:1459\u201367.","journal-title":"Neuropsychopharmacology"},{"key":"1700_CR34","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/sj.npp.1300169","volume":"28","author":"L Cervo","year":"2003","unstructured":"Cervo L, Carnovali F, Stark JA, Mennini T. Cocaine-seeking behavior in response to drug-associated stimuli in rats: Involvement of D3 and D2 dopamine receptors. Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol. 2003;28:1150\u20139.","journal-title":"Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol"},{"key":"1700_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.drugalcdep.2005.05.011","volume":"81","author":"K G\u00e1l","year":"2006","unstructured":"G\u00e1l K, Gyerty\u00e1n I. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats. Drug Alcohol Depend. 2006;81:63\u201370.","journal-title":"Drug Alcohol Depend"},{"key":"1700_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1527-3458.2007.00013.x","volume":"13","author":"Z-X Xi","year":"2007","unstructured":"Xi Z-X, Gardner EL. Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction. CNS Drug Rev. 2007;13:240\u201359.","journal-title":"CNS Drug Rev"},{"key":"1700_CR37","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.neuropharm.2008.12.007","volume":"56","author":"X-Q Peng","year":"2009","unstructured":"Peng X-Q, Ashby CR, Spiller K, Li X, Li J, Thomasson N, et al. The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats. Neuropharmacology. 2009;56:752\u201360.","journal-title":"Neuropharmacology"},{"key":"1700_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108113","volume":"172","author":"RC Campos","year":"2020","unstructured":"Campos RC, Dias C, Darlot F, Cador M. Double dissociation between actions of dopamine D1 and D2 receptors of the ventral and dorsolateral striatum to produce reinstatement of cocaine seeking behavior. Neuropharmacology. 2020;172:108113.","journal-title":"Neuropharmacology"},{"key":"1700_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrd3024","volume":"9","author":"S Rajagopal","year":"2010","unstructured":"Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov. 2010;9:373\u201386.","journal-title":"Nat Rev Drug Discov"},{"key":"1700_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev.pharmtox.010909.105800","volume":"52","author":"E Reiter","year":"2012","unstructured":"Reiter E, Ahn S, Shukla AK, Lefkowitz RJ. Molecular mechanism of \u03b2-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol. 2012;52:179\u201397.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1700_CR41","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.3390\/molecules26154509","volume":"26","author":"S Fritzwanker","year":"2021","unstructured":"Fritzwanker S, Schulz S, Kliewer A. SR-17018 stimulates atypical \u00b5-opioid receptor phosphorylation and dephosphorylation. Molecules. 2021;26:4509.","journal-title":"Molecules"},{"key":"1700_CR42","first-page":"715","volume":"19","author":"NK Singla","year":"2019","unstructured":"Singla NK, Skobieranda F, Soergel DG, Salamea M, Burt DA, Demitrack MA, et al. APOLLO-2: A randomized, placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the \u03bc-opioid receptor, for management of moderate to severe acute pain following abdominoplasty. Pain Pr J World Inst Pain. 2019;19:715\u201331.","journal-title":"Pain Pr J World Inst Pain"},{"key":"1700_CR43","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","volume":"185","author":"Y Zhuang","year":"2022","unstructured":"Zhuang Y, Wang Y, He B, He X, Zhou XE, Guo S, et al. Molecular recognition of morphine and fentanyl by the human \u03bc-opioid receptor. Cell. 2022;185:4361\u201375.","journal-title":"Cell"},{"key":"1700_CR44","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.cell.2020.04.053","volume":"181","author":"LM Slosky","year":"2020","unstructured":"Slosky LM, Bai Y, Toth K, Ray C, Rochelle LK, Badea A, et al. \u03b2-arrestin-biased allosteric modulator of NTSR1 selectively attenuates addictive behaviors. Cell. 2020;181:1364\u201379.","journal-title":"Cell"},{"key":"1700_CR45","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.2147\/DDDT.S188760","volume":"13","author":"B Kiss","year":"2019","unstructured":"Kiss B, N\u00e9methy Z, Fazekas K, Kurk\u00f3 D, Gyerty\u00e1n I, S\u00e1ghy K, et al. Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine. Drug Des Dev Ther. 2019;13:3229\u201348.","journal-title":"Drug Des Dev Ther"},{"key":"1700_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136092","volume":"760","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Liang Y. Involvement of GRK2 in modulating nalfurafine-induced reduction of excessive alcohol drinking in mice. Neurosci Lett. 2021;760:136092.","journal-title":"Neurosci Lett"},{"key":"1700_CR47","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/bph.14913","volume":"177","author":"AM Gutridge","year":"2020","unstructured":"Gutridge AM, Robins MT, Cassell RJ, Uprety R, Mores KL, Ko MJ, et al. G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder. Br J Pharmacol. 2020;177:1497\u2013513.","journal-title":"Br J Pharmacol"},{"key":"1700_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aam5402","volume":"11","author":"B Huang","year":"2018","unstructured":"Huang B, Li Y, Cheng D, He G, Liu X, Ma L. \u03b2-arrestin-biased \u03b2-adrenergic signaling promotes extinction learning of cocaine reward memory. Sci Signal. 2018;11:eaam5402.","journal-title":"Sci Signal"},{"key":"1700_CR49","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/npp.2010.186","volume":"36","author":"NM Urs","year":"2011","unstructured":"Urs NM, Daigle TL, Caron MG. A dopamine D1 receptor-dependent \u03b2-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice. Neuropsychopharmacology. 2011;36:551\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"1700_CR50","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuropharm.2015.07.009","volume":"99","author":"JR Schank","year":"2015","unstructured":"Schank JR, Nelson BS, Damadzic R, Tapocik JD, Yao M, King CE, et al. Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking. Neuropharmacology. 2015;99:106\u201314.","journal-title":"Neuropharmacology"},{"key":"1700_CR51","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1038\/s41386-018-0017-9","volume":"43","author":"J-F Liu","year":"2018","unstructured":"Liu JF, Seaman R, Siemian JN, Bhimani R, Johnson B, Zhang Y, et al. Role of trace amine-associated receptor 1 in nicotine\u2019s behavioral and neurochemical effects. Neuropsychopharmacology. 2018;43:2435\u201344.","journal-title":"Neuropsychopharmacology"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01700-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01700-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01700-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:02:34Z","timestamp":1777024954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01700-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1700"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01700-w","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}